rs1057519646
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PM5PP5
The NM_015295.3(SMCHD1):c.404G>A(p.Ser135Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S135C) has been classified as Pathogenic.
Frequency
Consequence
NM_015295.3 missense
Scores
Clinical Significance
Conservation
Publications
- arhinia, choanal atresia, and microphthalmiaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, ClinGen, Illumina
- facioscapulohumeral muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMCHD1 | NM_015295.3 | c.404G>A | p.Ser135Asn | missense_variant | Exon 3 of 48 | ENST00000320876.11 | NP_056110.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMCHD1 | ENST00000320876.11 | c.404G>A | p.Ser135Asn | missense_variant | Exon 3 of 48 | 5 | NM_015295.3 | ENSP00000326603.7 | ||
| SMCHD1 | ENST00000688342.1 | c.404G>A | p.Ser135Asn | missense_variant | Exon 3 of 47 | ENSP00000508422.1 | ||||
| SMCHD1 | ENST00000684915.1 | n.561G>A | non_coding_transcript_exon_variant | Exon 3 of 14 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhinia with choanal atresia and microphthalmia syndrome Pathogenic:2
- -
- -
SMCHD1-related disorder Pathogenic:1
The SMCHD1 c.404G>A variant is predicted to result in the amino acid substitution p.Ser135Asn. This variant has been reported in the de novo state in one individual with Bosma arhinia microphthalmia syndrome (BAMS) (Gordon et al. 2017. PubMed ID: 28067911). A different missense variant in the same codon (c.404G>T, p. Ser135Ile) was reported in the de novo state in one individual with BAMS (Shaw et al. 2017. PubMed ID: 28067909. Table S2). This variant has also been reported in individuals with Arhinia or Facioscapulohumeral muscular dystrophy type 2 (Ruprecht et al. 1978. PubMed ID: 672092; Shaw et al. 2017. PubMed ID: 28067909. Table S2; Mohassel et al. 2022. PubMed ID: 35121673). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at